Status:

RECRUITING

French Prospective Multicentric Study in Real World

Lead Sponsor:

Insulet Corporation

Conditions:

Diabetes

Diabetes Mellitus

Eligibility:

All Genders

2+ years

Brief Summary

The purpose of this postmarket clinical investigation is to evaluate the levels of glycemic control, quality of life, and satisfaction, as well as the patient experience, and acute diabetes complicati...

Detailed Description

Twelve-month, real-world, non-interventional, prospective follow-up of adult and pediatric patients aged more than 2 years old, prescribed one of the Dexcom (Dexcom G6 or G7) configurations commercial...

Eligibility Criteria

Inclusion Criteria:

  • Patient with T1D aged ≥ 2 years.
  • Patient prescribed a commercially available configuration of the Omnipod 5 System using a Dexcom sensor (Dexcom G6 or Dexcom G7).
  • Patient has never used the Omnipod 5 System prior to inclusion.
  • Patient has not objected to the use of their personal data for this study.
  • Patient or legal guardian has an email address and mobile phone number.
  • Patient (and legal guardians if the patient is a minor) is able to understand study information and Non-Opposition form.
  • Patient (and legal guardians if the patient is a minor) is able to understand and complete questionnaires in French.
  • Patient is covered by the local social security system.

Exclusion Criteria:

  • Patient is currently pregnant
  • Patient presents an allergy to the materials of the Omnipod 5 System (patch, cannula, CGM).
  • Patient is unable to be followed by the same investigation site for the duration of the study or is unwilling or unable to maintain contact with the healthcare professional.
  • Patient is already participating in a clinical trial or in another study precluding their participation in other studies.
  • Patient or legal guardian (for minors) is not able to understand and complete electronic questionnaires.
  • Adult under guardianship, curatorship or tutorship.
  • Adult otherwise deprived of liberty.

Key Trial Info

Start Date :

July 23 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 1 2027

Estimated Enrollment :

304 Patients enrolled

Trial Details

Trial ID

NCT07039942

Start Date

July 23 2025

End Date

May 1 2027

Last Update

April 9 2026

Active Locations (24)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (24 locations)

1

CHU Angers

Angers, France, 49100

2

CHU Besançon - Hôpital de Jean Minjoz

Besançon, France

3

APHP Hopital Avicenne

Bobigny, France, 93000

4

CHU Bordeaux - Hôpital Pellegrin

Bordeaux, France, 33000

French Prospective Multicentric Study in Real World | DecenTrialz